<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Equine Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Equine Sci</journal-id><journal-id journal-id-type="publisher-id">JES</journal-id><journal-title-group><journal-title>Journal of equine science</journal-title></journal-title-group><issn pub-type="ppub">1340-3516</issn><issn pub-type="epub">1347-7501</issn><publisher><publisher-name>The Japanese Society of Equine Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24834008</article-id><article-id pub-id-type="pmc">4019198</article-id><article-id pub-id-type="publisher-id">1315</article-id><article-id pub-id-type="doi">10.1294/jes.25.7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Regulation of Tenomodulin Expression Via Wnt/&#x003b2;-catenin Signaling in Equine Bone Marrow-derived Mesenchymal Stem
Cells</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>MIYABARA</surname><given-names>Shihori</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>YUDA</surname><given-names>Yohei</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>KASASHIMA</surname><given-names>Yoshinori</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>KUWANO</surname><given-names>Atsutoshi</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>ARAI</surname><given-names>Katsuhiko</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp">
<sup>*</sup>
</xref></contrib><aff id="aff1"><label>1</label><institution> Department of Tissue Physiology, Tokyo University of Agriculture and Technology, Tokyo 183-8509, Japan</institution></aff><aff id="aff2"><label>2</label><institution> Laboratory of Clinical Science and Pathobiology, Equine Research Institute, Japan Racing Association, Tochigi
320-8056, Japan</institution></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. e-mail:<email xlink:href="karai@cc.tuat.ac.jp">karai@cc.tuat.ac.jp</email></corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>4</month><year>2014</year></pub-date><pub-date pub-type="ppub"><year>2014</year></pub-date><volume>25</volume><issue>1</issue><fpage>7</fpage><lpage>13</lpage><history><date date-type="received"><day>06</day><month>11</month><year>2013</year></date><date date-type="accepted"><day>30</day><month>1</month><year>2014</year></date></history><permissions><copyright-statement>2014 The Japanese Society of Equine Science</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No
Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><title>ABSTRACT</title><p>Tenomodulin has been recognized as a biomarker for tendon differentiation, and its gene expression is regulated by several
transcription factors including Scleraxis and Mohawk. In this study, we found a novel regulatory mechanism of tenomodulin
expression. Equine bone marrow-derived mesenchymal stem cells (BMSCs) in monolayer culture showed a low mRNA level of tenomodulin
in comparison with the level in the tendon. When cultured in collagen gel containing a glycogen synthase kinase-3 (GSK-3)
inhibitor (BIO), expression of tenomodulin in BMSCs increased up to the level in the tendon. Participation of GSK-3 in its gene
expression was further demonstrated by a gene silencing experiment with small interference RNA corresponding to GSK-3, suggesting
that Wnt/&#x003b2;-catenin signaling mediated expression of tenomodulin. These results were confirmed by nuclear translocation of
&#x003b2;-catenin in BIO-treated BMSCs cultured in collagen gel. Under this culture condition, expression of tenomodulin-related
transcription factors including Scleraxis and Mohawk was not affected, suggesting that Wnt/&#x003b2;-catenin signaling was independent
from these transcription factors. Additionally, BIO strongly enhanced expression of type XIV collagen in collagen-embedded BMSCs
up to the level in the tendon, and other tendon-related extracellular matrix components such as decorin and fibromodulin were also
upregulated. Taken together, these results indicated that activation of Wnt/&#x003b2;-catenin signaling could induce differentiation of
BMSCs into tenomodulin-expressing tendon cells in collagen gel.</p></abstract><kwd-group><kwd>BMSCs</kwd><kwd>tendon</kwd><kwd>tenomodulin</kwd><kwd>Wnt signaling</kwd><kwd>ECM</kwd></kwd-group></article-meta></front><body><p>Equine tendonitis, injury to the superficial digital flexor (SDF) tendon, commonly occurs in racehorses as a result of excessive
mechanical force loaded onto the tendon tissue and is known to be an intractable disorder that tends to be recurrent. To solve such
clinical problems, the technical methods for autologous implantation of bone marrow-derived mesenchymal cells (BMSCs) into the SDF
tendon have been developed [<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r24" ref-type="bibr">24</xref>]. BMSCs are a population of pluripotent, non-hematopoietic marrow-derived cells maintained in
adult bone marrow, and these cells can differentiate into adipocytes, osteocytes, and chondrocytes [<xref rid="r7" ref-type="bibr">7</xref>, <xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r21" ref-type="bibr">21</xref>]. However, mechanism of
differentiation of BMSCs into the tendon cells has not been fully evaluated.</p><p>Tendons are tough bands of connective tissue that joins bones to muscles. The main component of the tendon is collagen fiber, which
mainly consists of collagen type I with minor fibrillar collagenous components, including collagen types III, V, and VI [<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r22" ref-type="bibr">22</xref>]. In addition to these fibrillar collagens, several
fibril surface-associated macromolecules are known to regulate tendon fibrillogenesis and the formation of tendon bundles.
Fibril-associated collagens with interrupted triple helices (FACITs) such as collagen types XII and XIV play significant roles in
tendon fibrogenesis and the ensuing formation of the extracellular matrix [<xref rid="r2" ref-type="bibr">2</xref>,&#x000a0;<xref rid="r3" ref-type="bibr">3</xref>,&#x000a0;<xref rid="r25" ref-type="bibr">25</xref>]. Among the small leucine-rich proteoglycans (SLRPs),
lumican and fibromodulin regulate fibril diameter [<xref rid="r10" ref-type="bibr">10</xref>], and decorin is a key regulator of
assembly of collagen fibrils in the tendon [<xref rid="r9" ref-type="bibr">9</xref>,&#x000a0;<xref rid="r26" ref-type="bibr">26</xref>].
Additionally, tenascin-C is known to be abundant in the developing tendon, bone and cartilage; however, its function still remains
unclear. On the other hand, tenomodulin is highly expressed in the tendon and recognized as a biomarker of tendon differentiation
[<xref rid="r18" ref-type="bibr">18</xref>,&#x000a0;<xref rid="r19" ref-type="bibr">19</xref>,&#x000a0;<xref rid="r23" ref-type="bibr">23</xref>].
Tenomodulin is a member of the type II transmembrane glycoproteins and is predominantly expressed in tendons, ligaments, and eyes.
Based on the analysis of tenomodulin-null mice, this glycoprotein functions as a regulator of proliferation and density of tendon
cells and is involved in collagen fibril maturation in the tendon [<xref rid="r8" ref-type="bibr">8</xref>].</p><p>In embryonic development, several Wnt signaling pathways have been recognized based on their functions including body axis
patterning, cell fate specification, cell proliferation, and cell migration as well as determination of differentiation fate in human
BMSCs [<xref rid="r20" ref-type="bibr">20</xref>]. In Wnt/&#x003b2;-catenin signaling, binding of Wnt protein to its receptor, Frizzled,
induces inhibition of the &#x003b2;-catenin destruction complex and then promotes stabilization and nuclear translocation of &#x003b2;-catenin.
Nuclear &#x003b2;-catenin forms the transcriptional complex and results in activation of the target genes. Glycogen synthase kinase-3 (GSK-3)
is known as a component of the &#x003b2;-catenin destruction complex, and inhibition of GSK-3 results in stabilization of &#x003b2;-catenin and
activation of sebsequent &#x003b2;-catenin-mediated gene expression.</p><p>In this study, we demonstrated that expression of tenomodulin in equine BMSCs cultured collagen gel was enhanced by inhibition of
GSK-3 with a selective inhibitor and gene silencing with small interference RNA (siRNA). Under these culture conditions, expression of
tendon-related extracellular matrix components (ECM) was also evaluated.</p><sec sec-type="materials|methods" id="s1"><title>Materials and Methods</title><sec><title>Cell culture</title><p>BMSCs were established from eight thoroughbred racehorses (3&#x02013;5 years old) as previously described [<xref rid="r13" ref-type="bibr">13</xref>], and their pluripotency was confirmed based on ability to differentiate into three cell lineages including
osteocytes, adipocytes, and chondrocytes as previously reported [<xref rid="r13" ref-type="bibr">13</xref>]. All animal procedures
were approved by the Ethics Committee for Laboratory Animals of the Japan Racing Association Equine Research Institute. These
BMSCs were propagated with growth medium comprised of Dulbecco&#x02019;s Modified Eagle&#x02019;s Medium (DMEM) (Sigma-Aldrich Inc., St. Louis,
MO, USA) supplemented with 20% fetal bovine serum (FBS, Invitrogen Corp., Carlsbad, CA, USA) and a
penicillin-streptomycin-neomycin solution (Sigma-Aldrich) in an atmosphere of humidified air containing 5% CO<sub>2</sub> at 37&#x002da;C.
These BMSCs were mixed and used for the following experiments at population doubling level 4. For collagen gel culture, 5 &#x000d7;
10<sup>5</sup> cells suspended in 500 <italic>&#x000b5;l</italic> of the growth medium were mixed with 50 <italic>&#x000b5;l</italic> of 10 &#x000d7;
DMEM (Biochrom, Leonorenstr, Berlin, Germany) and 450 <italic>&#x000b5;l</italic> of 1% collagen solution (Wako Pure Chemical Industries,
Osaka, Japan), and then poured into the wells of a 24-well plate. After polymerization of collagen gel, the medium was added and
cultured for 7 days, and these gels were then harvested for quantitative RT-PCR (qRT-PCR) analysis. For the experiment with a
signal inhibitor, 5 <italic>&#x003bc;</italic>M cytochalasin D, 100 <italic>&#x003bc;</italic>M genistein (tyrosine kinase inhibitor), 1
<italic>&#x003bc;</italic>M U0126 (MEK1 inhibitor) and 10 <italic>&#x003bc;</italic>M BIO (GSK-3 inhibitor) were added to the culture medium at
beginning of the cultivation. Cell transfection of siRNA corresponding to GSK-3&#x003b1;/&#x003b2; (Cell Signaling Technology Inc, Danvers, MA,
USA) into BMSCs was performed using X-tremeGENE siRNA Transfection Reagent (Roche Diagnostics, Mannheim, Germany). Briefly, BMSCs
(5 &#x000d7; 10<sup>5</sup> cells) were seeded into 100 mm culture dishes and cultured overnight. Two hours before transfection, the
culture medium was changed to DMEM containing 5% FBS, and then the cells in each dish were transfected with a mixture of 975
<italic>&#x000b5;l</italic> of Opti-MEM I (Invitrogen) and 25 <italic>&#x000b5;l</italic> of transfection reagent containing 0.15
<italic>&#x003bc;</italic>M of siRNA. After culture overnight, cells were trypsinized and applied to collagen gel culture for 72 hr,
total RNA was then extracted from the collagen gel.</p></sec><sec><title>qRT-PCR</title><p>Normal SDF tendon tissues were obtained from two adult (3-year-old) male thoroughbred racehorses. Whole tissues were powdered
using a stainless ball mill under liquid nitrogen and mixed. Total RNA in tissue powder and cultured BMSCs was isolated by RNAiso
Plus (Takara, Shiga, Japan) according to the manufacturer&#x02019;s protocol. Complementary DNA was prepared by reverse transcription of
DNase I (Roche)-treated total RNA with a One Step SYBR PrimeScript RT-PCR Kit (Takara), and then qRT-PCR was performed with a
Thermal Cycler Dice Real Time System (Takara) using SYBR Premix Ex Taq II (Takara). Several matrix-related components were
amplified using the specific primer sets shown in <xref rid="tbl_001" ref-type="table">Table 1</xref>
<table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Sequences of PCR primer sets used for qRT-PCR</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1">Gene</th><th valign="bottom" align="center" rowspan="1" colspan="1">Sequence</th><th valign="bottom" align="center" rowspan="1" colspan="1">Sequence</th><th valign="bottom" align="center" rowspan="1" colspan="1">Anealing temp</th><th valign="bottom" align="center" rowspan="1" colspan="1">Size</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>GAPDH</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;-
GTGTCCCCACCCCTAACG -3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;- AGTGTAGCCCAGGATGCC -3&#x000b4;</td><td align="center" rowspan="1" colspan="1">55.1</td><td align="left" rowspan="1" colspan="1">131</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Scleraxis</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;- CCCCCACGGACCTGACTC -3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;-
GGTAGGAAGCCAGCACGG -3&#x000b4;</td><td align="center" valign="bottom" rowspan="1" colspan="1">59.6</td><td align="left" valign="bottom" rowspan="1" colspan="1">167</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Mohawk</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;-
TAATCCCGTTCACCATCC -3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;- CTTTGCCTTGTCTTTCCC -3&#x000b4;</td><td align="center" valign="bottom" rowspan="1" colspan="1">52.7</td><td align="left" valign="bottom" rowspan="1" colspan="1">195</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Tenomodulin</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;- GGCGGGTTATCTGTCGTG -3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;- TACCAGGAGCCAAATGCC -3&#x000b4;</td><td align="center" valign="bottom" rowspan="1" colspan="1">53.0 </td><td align="left" valign="bottom" rowspan="1" colspan="1">169</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>NKD1</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;- CACAGGAAGCCCAAGCAC -3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;- TTCGTGGTGGTGGTGATG -3&#x000b4;</td><td align="center" valign="bottom" rowspan="1" colspan="1">59.2 </td><td align="left" valign="bottom" rowspan="1" colspan="1">183</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Col1a2</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;- GTGGAAAAGGTGAACAGG -3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;- CAATAGGACCAGCAGGAC -3&#x000b4;</td><td align="center" rowspan="1" colspan="1">55.3</td><td align="left" rowspan="1" colspan="1">198</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Col3a1</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;- CCTGGTTACTGCTTGCTC -3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;- GAATCTCTGGGTTGGGAC -3&#x000b4;</td><td align="center" rowspan="1" colspan="1">52.2</td><td align="left" rowspan="1" colspan="1">213</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Col12a1</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;- TTTTATGTGAGCCGACTG
-3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;- TACTCATCTTCCACCACG -3&#x000b4;</td><td align="center" rowspan="1" colspan="1">49.1</td><td align="left" rowspan="1" colspan="1">98</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Col14a1</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;-
CTGGACGATGGAAGTGAG -3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;- GTGACCCTGAACTGCTGC -3&#x000b4;</td><td align="center" rowspan="1" colspan="1">52.8</td><td align="left" rowspan="1" colspan="1">215</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Decorin</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;- TTATCAAAGTGCCTGGTG -3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;- CATAGACACATCGGAAGG -3&#x000b4;</td><td align="center" rowspan="1" colspan="1">51.1</td><td align="left" rowspan="1" colspan="1">204</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Fibromodulin</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;- GCTTCTGCTGAGGGACAC -3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;-
GATTTCTGGGGTTGGGAC -3&#x000b4;</td><td align="center" rowspan="1" colspan="1">52.1</td><td align="left" rowspan="1" colspan="1">91</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Lumican</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;- ATTTCATCACAAGCACAG -3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;- TGACTTCCATACAACCAG -3&#x000b4;</td><td align="center" rowspan="1" colspan="1">45.6</td><td align="left" rowspan="1" colspan="1">131</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Tenascin-C</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">U: 5&#x000b4;- GAACACGGTGGAGTATGC
-3&#x000b4;</td><td align="left" valign="bottom" rowspan="1" colspan="1">L: 5&#x000b4;- TTGGTAGTGATGGCTGAG -3&#x000b4;</td><td align="center" valign="bottom" rowspan="1" colspan="1">52.1</td><td align="left" valign="bottom" rowspan="1" colspan="1">105</td></tr></tbody></table></table-wrap>, and nucleotide sequences of
amplified DNA fragments were confirmed using an autosequencer (ABI, Life Technologies Japan, Tokyo, Japan).</p></sec><sec><title>Histological analysis</title><p>Collagen gels containing BMSCs were fixed with 4% paraformaldehyde for 6 hr, dehydrated with graded ethanol, immersed in xylene,
and then embedded in paraffin. Sections 4 <italic>&#x003bc;</italic>m thick were deparaffinized and stained with hematoxylin and eosin.
Immunofluorescent microscopy was performed to analyze the localization of &#x003b2;-catenin protein. Deparaffinized sections were
incubated with an anti-&#x003b2;-catenin polyclonal antibody (Sigma-Aldrich) at 4&#x002da;C overnight, followed by incubation with
tetramethylrhodamine-5-(and 6)-isothiocyanate (TRITC)-conjugated secondary antibody (Chemicon International Inc., Temecula, CA,
USA) and DAPI for one hour at room temperature. Resulting slides were mounted with aqueous mounting medium (Mount-Quick Aqueous,
Daido Sangyo Co., Ltd., Tokyo, Japan), and images were acquired with an LSM710 confocal laser-scanning microscope (Carl Zeiss
Microscopy GmbH, Munich, Germany).</p></sec><sec><title>Statistical analysis</title><p>The results are shown as the mean &#x000b1; SD of a representative experiment performed in triplicate. The statistical significance of
differences between the values of the respective experimental groups and controls was determined by Mann-Whitney&#x02019;s U test, and
values of P&#x0003c;0.05 were considered significant.</p></sec></sec><sec sec-type="results" id="s2"><title>Results</title><sec><title>Comparison of tendon-related components between tendon and monolayer BMSCs by qRT-PCR analysis</title><p>Levels of mRNA corresponding to tendon-related components were compared between the tendon and BMSCs by qRT-PCR analysis (<xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Comparison of mRNA
level between the tenodon and monolayer BMSC by qRT-PCR analysis</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="center" rowspan="1" colspan="1">Gene</th><th valign="bottom" align="center" rowspan="1" colspan="1">Tenodon</th><th valign="bottom" align="center" rowspan="1" colspan="1">Monolayer
BMSC</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Tenomodulin</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">0.00057 &#x000b1; 0.00012*</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.00006 &#x000b1; 0.00001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Col1a2</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">0.11810 &#x000b1; 0.03612</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.15139 &#x000b1; 0.02522</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Col3a1</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">0.00880 &#x000b1; 0.00251</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.13373 &#x000b1; 0.02121</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Col12a1</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">0.07856 &#x000b1; 0.01431</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.24827 &#x000b1; 0.03142</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Col14a1</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">0.01458 &#x000b1; 0.00373*</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.00003 &#x000b1; 0.00001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Decorin</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">29.65080 &#x000b1; 2.85643*</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.70031 &#x000b1;
0.14381</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Fibromodulin</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">0.11311 &#x000b1; 0.02413*</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.00599 &#x000b1; 0.00143</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Lumican</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">1.16473 &#x000b1; 0.28143</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.94606 &#x000b1; 0.14877</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Tenascin-C</italic></td><td align="left" valign="bottom" rowspan="1" colspan="1">0.01858 &#x000b1; 0.00143</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.01010 &#x000b1;
0.00131</td></tr></tbody></table><table-wrap-foot><p>The values are expressed as means &#x000b1; SD obtained from three independent
experiments. * P&#x0003c;0.05 vs. monolayer BMSC.</p></table-wrap-foot></table-wrap>). The level of tenomodulin mRNA of BMSCs in
monolayer culture was about 1/10 of the level in the tendon. Among major tendon collagens, no significant difference in mRNA
levels corresponding to collagen type I &#x003b1;2 chain (Col1a2) and type III &#x003b1;1 chain (Col3a1) was observed between the tendon and
monolayer BMSCs, while the level of the type XII &#x003b1;1 chain (Col12a1) in BMSCs was rather higher than that in the tendon. On the
other hand, the level of mRNA corresponding to the type XIV collagen &#x003b1;1 chain (Col14a1) in BMSCs was about 1/50 of the level in
the tendon. Among other tendon-related ECM components, the mRNA levels corresponding to decorin and fibromodulin in BMSCs showed
about 1/40 and 1/20 of the level of the tendon, respectively, while there was no significant difference in mRNA level of lumican
and tenascin-C. These results indicated that Col14a1, decorin, and fibromodulin showed lower expression in monolayer BMSCs than in
the tendon, suggesting that these components could be additional differentiation markers of tendon.</p></sec><sec><title>Regulation of tenomodulin expression via canonical Wnt/&#x003b2;-catenin signaling</title><p>To evaluate the effect of the GSK-3 inhibitor on expression of tenomodulin, BMSCs were cultured in collagen gel with BIO. As a
result, BIO intensely enhanced expression of tenomodulin mRNA, whereas other signal inhibitors including cytochalasin D,
genistein, and U0126 did not affect its mRNA level (<xref ref-type="fig" rid="fig_001">Fig. 1a</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>qRT-PCR analysis of tenomodulin (a) and NKD1
(b) in BMSCs cultured in collagen gel with cytochalasin D (cytoD), genistein, U0126, or BIO, respectively. The values are
expressed relative to the control (mean &#x000b1; SD) from three independent experiments (<italic>*</italic>
P<italic>&#x0003c;</italic>0.05).</p></caption><graphic xlink:href="jes-25-007-g001"/></fig>). These results were supported
by BIO-mediated induction of naked cuticle 1 homolog (NKD1), which is a well-known downstream target of Wnt signaling (<xref ref-type="fig" rid="fig_001">Fig. 1b</xref>). Participation of Wnt/&#x003b2;-catenin signaling in tenomodulin expression was further
confirmed by a gene silencing experiment for GSK-3&#x003b1;/&#x003b2;. While the mRNA level of tenomodulin in BIO-treated BMSCs was upregulated by
approximately 3-fold within 72 hr compared with control BMSCs, the mRNA level of GSK-3-knockdown BMSCs similarly increased when
the cells were cultured in collagen gel without BIO (<xref ref-type="fig" rid="fig_002">Fig. 2</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p>Effect of siRNA corresponding to GSK-3&#x003b1;/&#x003b2; on
expression of tenomodulin mRNA. qRT-PCR analysis showed the level in untreated BMSCs without BIO (non), with BIO, or with
GSK-3&#x003b1;/&#x003b2;-knockdown BMSCs cultured for 72 hr in collagen gel. The values are expressed relative to the control (mean &#x000b1; SD)
from three independent experiments. Different superscript letters indicate significant differences
(P<italic>&#x0003c;</italic>0.05).</p></caption><graphic xlink:href="jes-25-007-g002"/></fig>). These results demonstrated
that inhibition of GSK-3 brought upregulation of tenomodulin. Next, to evaluate nuclear translocation of &#x003b2;-catenin, histological
examination was performed. The cells in the control gel showed a fibroblastic shape, and assemblies of collagen fiber were
observed around the cells (<xref ref-type="fig" rid="fig_003">Fig. 3a</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p>Histology of BMSCs embedded in collagen gel cultured for 7 days.
HE staining of BMSCs cultured in collagen gel without (a) or with BIO (b). Arrows indicate the assembly of collagen fibers
observed in the control gel, and arrowheads indicate very thin cytoplasm of round shaped BMSCs formed in BIO-supplemented
gel. Immunohistochemical staining of &#x003b2;-catenin (red) in BMSCs cultured for 7 days in collagen gel without (c) or with BIO
(d). Nuclear stainings were performed with DAPI (blue; bars=20 <italic>&#x003bc;</italic>m).</p></caption><graphic xlink:href="jes-25-007-g003"/></fig>, arrows), whereas BIO-treated cells had a large round shape with very thin cytoplasm
(<xref ref-type="fig" rid="fig_003">Fig. 3b</xref>, arrowheads). Immunocytochemical staining of &#x003b2;-catenin demonstrated nuclear
translocation of &#x003b2;-catenin in BIO-treated BMSCs (<xref ref-type="fig" rid="fig_003">Fig. 3d</xref>), while &#x003b2;-catenin was located
in the cytoplasm in untreated cells (<xref ref-type="fig" rid="fig_003">Fig. 3c</xref>). These results demonstrated that
Wnt/&#x003b2;-catenin signaling regulated expression of tenomodulin in BMSCs.</p></sec><sec><title>Induction of tendon-related components in BMSCs cultured in collagen gel by activation of Wnt/&#x003b2;-catenin signaling</title><p>The effect of BIO on tenomodulin expression was not observed in monolayer culture. Tenomodulin expression was slightly enhanced
when cultured in collagen gel and was augmented by Wnt/&#x003b2;-catenin activation (<xref ref-type="fig" rid="fig_004">Fig. 4a</xref><fig orientation="portrait" fig-type="figure" id="fig_004" position="float"><label>Fig. 4.</label><caption><p>qRT-PCR analysis of
mRNA levels of tenomodulin (tnmd; a), Scleraxis (b), Mohawk (c), type XIV collagen (col14a1; d), decorin (e) and
fibromodulin (Fmod; f) in monolayer culture or collagen gel with or without BIO (non). The values are expressed relative to
the control (mean &#x000b1; SD) from three independent experiments. Different superscript letters indicate significant differences
(P<italic>&#x0003c;</italic>0.05).</p></caption><graphic xlink:href="jes-25-007-g004"/></fig>). Regarding transcription
factors, which are thought to regulate tenomodulin expression, both Scleraxis (<xref ref-type="fig" rid="fig_004">Fig. 4b</xref>)
and Mohawk (<xref ref-type="fig" rid="fig_004">Fig. 4c</xref>) were not apparently affected by addition of BIO in both culture
conditions. Whereas BIO did not affect expression of Col14a1 (<xref ref-type="fig" rid="fig_004">Fig. 4d</xref>), decorin (<xref ref-type="fig" rid="fig_004">Fig. 4e</xref>), and fibromodulin (<xref ref-type="fig" rid="fig_004">Fig. 4f</xref>) in monolayer
BMSCs, thier expressions were significantly enhanced in BIO-containing collagen gel. The value of Col14a1 relative to GAPDH in
monolayer BMSCs was upregulated by 160-fold by addition of BIO to collagen gel, while the relative values for decorin and
tenomodulin increased by 7-fold and 2-fold compared with the values in monolayer, respectively.</p></sec></sec><sec sec-type="discussion" id="s3"><title>Discussion</title><p>Tenomodulin has been recognized as the marker of tendon differentiation, however, the mechanism of its transcriptional regulation
remains unclear. Two DNA-binding proteins have been identified as being involved in vertebrate tendon formation, the basic
helix-loop-helix transcription factor, Scleraxis [<xref rid="r17" ref-type="bibr">17</xref>], and the Mohawk homeobox [<xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r15" ref-type="bibr">15</xref>]. Scleraxis-null mice displayed decreased
expression of type I collagen as well as tenomodulin on embryonic day 16.5 [<xref rid="r15" ref-type="bibr">15</xref>]. On the other
hand, analysis of Mohawk-null mice indicated that this homeobox regulated tenomodulin expression in the embryo [<xref rid="r12" ref-type="bibr">12</xref>], while expression of type I collagen was regulated in the adult stage [<xref rid="r15" ref-type="bibr">15</xref>]. Additionally, mice with a mutation in the early growth response transcription factors, Egr1, showed
downregulation of Scleraxis, Mohawk and tenomodulin as well as type XIV collagen [<xref rid="r14" ref-type="bibr">14</xref>].
<italic>In vitro</italic> studies demonstrated that Smad3, the mediator of TGF&#x003b2; signaling, binds both Scleraxis and Mohawk and
that loss of Smad3 results in reduced protein expression of the matrix components including type I collagen and tenascin-C [<xref rid="r4" ref-type="bibr">4</xref>]. Furthermore, Scleraxis could also induce to differentiation of BMSCs into the lineage of
tendon cells. It was also reported that forced expression of Scleraxis induced human BMSCs to express tendon-related ECM components
in addition to tenomodulin [<xref rid="r1" ref-type="bibr">1</xref>] and that the combination of forced expression of Scleraxis and
mechanical stress converted human ES cells to tendon cells [<xref rid="r6" ref-type="bibr">6</xref>]. These previous studies
demonstrated that tenomodulin is regulated several transcription factors; however, there is no information concerning external
factors that directly upregulate tendon-related differentiation markers.</p><p>In this study, we found that a selective inhibitor of GSK-3, BIO, increased the mRNA level of tenomodulin and nuclear translocation
of &#x003b2;-catenin in BMSCs cultured in collagen gel. While the level of tenomodulin mRNA in monolayer BMSCs was about 1/10 of that in the
tendon, the mRNA level was slightly increased in collagen gel culture and further enhanced in the presence of BIO. Collagen gel
culture is known to produce an artificially created environment in which biological cells are permitted to express specific
phenotypes. It was recently reported that collagen lattice stimulated human BMSCs and increased the nuclear &#x003b2;-catenin protein level
[<xref rid="r16" ref-type="bibr">16</xref>]. Our results also indicated slight upregulation of tenomodulin in collagen gel without
BIO (<xref ref-type="fig" rid="fig_004">Fig. 4a</xref>). Taking these findings into account, equine BMSCs may also upregulate
&#x003b2;-catenin in collagen gel, and so further stabilization of &#x003b2;-catenin by BIO could contribute to upregulation of tenomodulin in
BMSCs.</p><p>Next, whether inhibition of GSK-3 affects expression of tenomodulin-regulating transcription factors including Scleraxis and Mohawk
was evaluated. The results showed that theses transcription factors did not significantly changed under several culture conditions,
suggesting a new regulation pathway for expression of tenomodulin via the Wnt/&#x003b2;-catenin signaling pathway. Regarding the
tendon-related ECM components, the mRNA level of Col14a1, decorin, and fibromodulin were quite low in monolayer BMSCs, as shown in
<xref rid="tbl_002" ref-type="table">Table 2</xref>, as compared with the levels in the tendon. Addition of BIO significantly
increased the mRNA levels of these components in collagen gel compared with those in monolayer culture. The level for Col14a1
relative to GAPDH in monolayer BMSCs was less than 1/100 of that in the tendon, and BIO increased the level up to that in the tendon
in BMSCs culture in collagen gel (<xref ref-type="fig" rid="fig_004">Fig. 4d</xref>). On the other hand, BIO increased expression of
decorin and fibromodulin by 3- to 4-fold in comparison with the expression in monolayer culture. These results indicated that
Wnt/&#x003b2;-catenin signaling also stimulated expression of tendon-related ECM components in addition to tenomodulin. Taking the above
into account, activation of Wnt/&#x003b2;-catenin signaling shifted BMSCs cultured in collagen gel to tenomodulin-expressing tendon cells,
but the tendon-related ECM components, except for Col14a1 were not fully upregulated to the level of the tendon. Thus, further
studies to develop a culture system to enhance expression of these tendon-related ECM components will be needed.</p></sec></body><back><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Alberton</surname><given-names>P.</given-names></name><name><surname>Popov</surname><given-names>C.</given-names></name><name><surname>Pr&#x000e4;gert</surname><given-names>M.</given-names></name><name><surname>Kohler</surname><given-names>J.</given-names></name><name><surname>Shukunami</surname><given-names>C.</given-names></name><name><surname>Schieker</surname><given-names>M.</given-names></name><name><surname>Docheva</surname><given-names>D.</given-names></name></person-group><year>2012</year>
<article-title>Conversion of human bone marrow-derived mesenchymal stem cells into tendon progenitor cells by
ectopic expression of scleraxis</article-title>. <source><italic>Stem Cells Dev.</italic></source><volume>21</volume>:
<fpage>846</fpage>&#x02013;<lpage>858</lpage>
<pub-id pub-id-type="pmid">21988170</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Ansorge</surname><given-names>H.L.</given-names></name><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Veit</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>M.</given-names></name><name><surname>Klement</surname><given-names>J.F.</given-names></name><name><surname>Beason</surname><given-names>D.P.</given-names></name><name><surname>Soslowsky</surname><given-names>L.J.</given-names></name><name><surname>Koch</surname><given-names>M.</given-names></name><name><surname>Birk</surname><given-names>D.E.</given-names></name></person-group><year>2009</year>
<article-title>Type XIV collagen regulates fibrillogenesis: PREMATURE COLLAGEN FIBRIL GROWTH AND TISSUE
DYSFUNCTION IN NULL MICE</article-title>. <source><italic>J. Biol. Chem.</italic></source><volume>284</volume>:
<fpage>8427</fpage>&#x02013;<lpage>8438</lpage>
<pub-id pub-id-type="pmid">19136672</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Arai</surname><given-names>K.</given-names></name><name><surname>Kasashima</surname><given-names>Y.</given-names></name><name><surname>Kobayashi</surname><given-names>A.</given-names></name><name><surname>Kuwano</surname><given-names>A.</given-names></name><name><surname>Yoshihara</surname><given-names>T.</given-names></name></person-group><year>2002</year>
<article-title>TGF-beta alters collagen XII and XIV mRNA levels in cultured equine tenocytes</article-title>.
<source><italic>Matrix Biol.</italic></source><volume>21</volume>: <fpage>243</fpage>&#x02013;<lpage>250</lpage>
<pub-id pub-id-type="pmid">12009330</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Berthet</surname><given-names>E.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Butcher</surname><given-names>K.</given-names></name><name><surname>Schneider</surname><given-names>R.A.</given-names></name><name><surname>Alliston</surname><given-names>T.</given-names></name><name><surname>Amirtharajah</surname><given-names>M.</given-names></name></person-group><year>2013</year>
<article-title>Smad3 binds Scleraxis and Mohawk and regulates tendon matrix organization</article-title>.
<source><italic>J. Orthop. Res.</italic></source><volume>31</volume>: <fpage>1475</fpage>&#x02013;<lpage>1483</lpage>
<pub-id pub-id-type="pmid">23653374</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Carvalho</surname><given-names>H.F.</given-names></name><name><surname>Felisbino</surname><given-names>S.L.</given-names></name><name><surname>Keene</surname><given-names>D.R.</given-names></name><name><surname>Vogel</surname><given-names>K.G.</given-names></name></person-group><year>2006</year>
<article-title>Identification, content, and distribution of type VI collagen in bovine tendons</article-title>.
<source><italic>Cell Tissue Res.</italic></source><volume>325</volume>: <fpage>315</fpage>&#x02013;<lpage>324</lpage>
<pub-id pub-id-type="pmid">16568302</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Yin</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>J.L.</given-names></name><name><surname>Shen</surname><given-names>W.L.</given-names></name><name><surname>Liu</surname><given-names>H.H.</given-names></name><name><surname>Tang</surname><given-names>Q.M.</given-names></name><name><surname>Fang</surname><given-names>Z.</given-names></name><name><surname>Lu</surname><given-names>L.R.</given-names></name><name><surname>Ji</surname><given-names>J.</given-names></name><name><surname>Ouyang</surname><given-names>H.W.</given-names></name></person-group><year>2012</year>
<article-title>Force and scleraxis synergistically promote the commitment of human ES cells derived MSCs to
tenocytes</article-title>. <source><italic>Sci. Rep.</italic></source><volume>2</volume>: <fpage>977</fpage>
<pub-id pub-id-type="pmid">23243495</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>De
Schauwer</surname><given-names>C.</given-names></name><name><surname>Meyer</surname><given-names>E.</given-names></name><name><surname>Van de
Walle</surname><given-names>G.R.</given-names></name><name><surname>Van
Soom</surname><given-names>A.</given-names></name></person-group><year>2011</year>
<article-title>Markers of stemness in equine mesenchymal stem cells: a plea for uniformity</article-title>.
<source><italic>Theriogenology</italic></source><volume>75</volume>: <fpage>1431</fpage>&#x02013;<lpage>1443</lpage>
<pub-id pub-id-type="pmid">21196039</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Docheva</surname><given-names>D.</given-names></name><name><surname>Hunziker</surname><given-names>E.B.</given-names></name><name><surname>F&#x000e4;ssler</surname><given-names>R.</given-names></name><name><surname>Brandau</surname><given-names>O.</given-names></name></person-group><year>2005</year>
<article-title>Tenomodulin is necessary for tenocyte proliferation and tendon maturation</article-title>.
<source><italic>Mol. Cell Biol.</italic></source><volume>25</volume>: <fpage>699</fpage>&#x02013;<lpage>705</lpage>
<pub-id pub-id-type="pmid">15632070</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Dunkman</surname><given-names>A.A.</given-names></name><name><surname>Buckley</surname><given-names>M.R.</given-names></name><name><surname>Mienaltowski</surname><given-names>M.J.</given-names></name><name><surname>Adams</surname><given-names>S.M.</given-names></name><name><surname>Thomas</surname><given-names>S.J.</given-names></name><name><surname>Satchell</surname><given-names>L.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Pathmanathan</surname><given-names>L.</given-names></name><name><surname>Beason</surname><given-names>D.P.</given-names></name><name><surname>Iozzo</surname><given-names>R.V.</given-names></name><name><surname>Birk</surname><given-names>D.E.</given-names></name><name><surname>Soslowsky</surname><given-names>L.J.</given-names></name></person-group><year>2013</year>
<article-title>Decorin expression is important for age-related changes in tendon structure and mechanical
properties</article-title>. <source><italic>Matrix Biol.</italic></source><volume>32</volume>:
<fpage>3</fpage>&#x02013;<lpage>13</lpage>
<pub-id pub-id-type="pmid">23178232</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Ezura</surname><given-names>Y.</given-names></name><name><surname>Chakravarti</surname><given-names>S.</given-names></name><name><surname>Oldberg</surname><given-names>A.</given-names></name><name><surname>Chervoneva</surname><given-names>I.</given-names></name><name><surname>Birk</surname><given-names>D.E.</given-names></name></person-group><year>2000</year>
<article-title>Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in
developing mouse tendons</article-title>. <source><italic>J. Cell Biol.</italic></source><volume>151</volume>:
<fpage>779</fpage>&#x02013;<lpage>788</lpage>
<pub-id pub-id-type="pmid">11076963</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Fortier</surname><given-names>L.A.</given-names></name><name><surname>Smith</surname><given-names>R.K.</given-names></name></person-group><year>2008</year>
<article-title>Regenerative medicine for tendinous and ligamentous injuries of sport horses</article-title>.
<source><italic>Vet. Clin. North Am. Equine Pract.</italic></source><volume>24</volume>:
<fpage>191</fpage>&#x02013;<lpage>201</lpage>
<pub-id pub-id-type="pmid">18314043</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Ito</surname><given-names>Y.</given-names></name><name><surname>Toriuchi</surname><given-names>N.</given-names></name><name><surname>Yoshitaka</surname><given-names>T.</given-names></name><name><surname>Ueno-Kudoh</surname><given-names>H.</given-names></name><name><surname>Sato</surname><given-names>T.</given-names></name><name><surname>Yokoyama</surname><given-names>S.</given-names></name><name><surname>Nishida</surname><given-names>K.</given-names></name><name><surname>Akimoto</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Miyaki</surname><given-names>S.</given-names></name><name><surname>Asahara</surname><given-names>H.</given-names></name></person-group><year>2010</year>
<article-title>The Mohawk homeobox gene is a critical regulator of tendon differentiation</article-title>.
<source><italic>Proc. Natl. Acad. Sci. USA</italic></source><volume>107</volume>: <fpage>10538</fpage>&#x02013;<lpage>10542</lpage>
<pub-id pub-id-type="pmid">20498044</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Kasashima</surname><given-names>Y.</given-names></name><name><surname>Ueno</surname><given-names>T.</given-names></name><name><surname>Tomita</surname><given-names>A.</given-names></name><name><surname>Goodship</surname><given-names>A.E.</given-names></name><name><surname>Smith</surname><given-names>R.K.</given-names></name></person-group><year>2011</year>
<article-title>Optimisation of bone marrow aspiration from the equine sternum for the safe recovery of
mesenchymal stem cells</article-title>. <source><italic>Equine Vet. J.</italic></source><volume>43</volume>:
<fpage>288</fpage>&#x02013;<lpage>294</lpage>
<pub-id pub-id-type="pmid">21492205</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Lejard</surname><given-names>V.</given-names></name><name><surname>Blais</surname><given-names>F.</given-names></name><name><surname>Guerquin</surname><given-names>M.J.</given-names></name><name><surname>Bonnet</surname><given-names>A.</given-names></name><name><surname>Bonnin</surname><given-names>M.A.</given-names></name><name><surname>Havis</surname><given-names>E.</given-names></name><name><surname>Malbouyres</surname><given-names>M.</given-names></name><name><surname>Bidaud</surname><given-names>C.B.</given-names></name><name><surname>Maro</surname><given-names>G.</given-names></name><name><surname>Gilardi-Hebenstreit</surname><given-names>P.</given-names></name><name><surname>Rossert</surname><given-names>J.</given-names></name><name><surname>Ruggiero</surname><given-names>F.</given-names></name><name><surname>Duprez</surname><given-names>D.</given-names></name></person-group><year>2011</year>
<article-title>EGR1 and EGR2 involvement in vertebrate tendon differentiation</article-title>.
<source><italic>J. Biol. Chem.</italic></source><volume>286</volume>: <fpage>5855</fpage>&#x02013;<lpage>5867</lpage>
<pub-id pub-id-type="pmid">21173153</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Watson</surname><given-names>S.S.</given-names></name><name><surname>Lan</surname><given-names>Y.</given-names></name><name><surname>Keene</surname><given-names>D.R.</given-names></name><name><surname>Ovitt</surname><given-names>C.E.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Schweitzer</surname><given-names>R.</given-names></name><name><surname>Jiang</surname><given-names>R.</given-names></name></person-group><year>2010</year>
<article-title>The atypical homeodomain transcription factor Mohawk controls tendon
morphogenesis</article-title>. <source><italic>Mol. Cell Biol.</italic></source><volume>30</volume>:
<fpage>4797</fpage>&#x02013;<lpage>4807</lpage>
<pub-id pub-id-type="pmid">20696843</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Mauney</surname><given-names>J.</given-names></name><name><surname>Volloch</surname><given-names>V.</given-names></name></person-group><year>2009</year>
<article-title>Collagen I matrix contributes to determination of adult human stem cell lineage via
differential, structural conformation-specific elicitation of cellular stress response</article-title>. <source><italic>Matrix
Biol.</italic></source><volume>28</volume>: <fpage>251</fpage>&#x02013;<lpage>262</lpage>
<pub-id pub-id-type="pmid">19375506</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Murchison</surname><given-names>N.D.</given-names></name><name><surname>Price</surname><given-names>B.A.</given-names></name><name><surname>Conner</surname><given-names>D.A.</given-names></name><name><surname>Keene</surname><given-names>D.R.</given-names></name><name><surname>Olson</surname><given-names>E.N.</given-names></name><name><surname>Tabin</surname><given-names>C.J.</given-names></name><name><surname>Schweitzer</surname><given-names>R.</given-names></name></person-group><year>2007</year>
<article-title>Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from
muscle-anchoring tendons</article-title>. <source><italic>Development</italic></source><volume>134</volume>:
<fpage>2697</fpage>&#x02013;<lpage>2708</lpage>
<pub-id pub-id-type="pmid">17567668</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Oshima</surname><given-names>Y.</given-names></name><name><surname>Sato</surname><given-names>K.</given-names></name><name><surname>Tashiro</surname><given-names>F.</given-names></name><name><surname>Miyazaki</surname><given-names>J.</given-names></name><name><surname>Nishida</surname><given-names>K.</given-names></name><name><surname>Hiraki</surname><given-names>Y.</given-names></name><name><surname>Tano</surname><given-names>Y.</given-names></name><name><surname>Shukunami</surname><given-names>C.</given-names></name></person-group><year>2004</year>
<article-title>Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with
chondromodulin-I</article-title>. <source><italic>J. Cell Sci.</italic></source><volume>117</volume>:
<fpage>2731</fpage>&#x02013;<lpage>2744</lpage>
<pub-id pub-id-type="pmid">15150318</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Oshima</surname><given-names>Y.</given-names></name><name><surname>Shukunami</surname><given-names>C.</given-names></name><name><surname>Honda</surname><given-names>J.</given-names></name><name><surname>Nishida</surname><given-names>K.</given-names></name><name><surname>Tashiro</surname><given-names>F.</given-names></name><name><surname>Miyazaki</surname><given-names>J.</given-names></name><name><surname>Hiraki</surname><given-names>Y.</given-names></name><name><surname>Tano</surname><given-names>Y.</given-names></name></person-group><year>2003</year>
<article-title>Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related
angiogenesis inhibitor, in mouse eyes</article-title>. <source><italic>Invest. Ophthalmol. Vis.
Sci.</italic></source><volume>44</volume>: <fpage>1814</fpage>&#x02013;<lpage>1823</lpage>
<pub-id pub-id-type="pmid">12714610</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Qiu</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Kassem</surname><given-names>M.</given-names></name></person-group><year>2011</year>
<article-title>Activation of non-canonical Wnt/JNK pathway by Wnt3a is associated with differentiation fate
determination of human bone marrow stromal (mesenchymal) stem cells</article-title>. <source><italic>Biochem. Biophys. Res.
Commun.</italic></source><volume>413</volume>: <fpage>98</fpage>&#x02013;<lpage>104</lpage>
<pub-id pub-id-type="pmid">21875572</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Ranera</surname><given-names>B.</given-names></name><name><surname>Lyahyai</surname><given-names>J.</given-names></name><name><surname>Romero</surname><given-names>A.</given-names></name><name><surname>V&#x000e1;zquez</surname><given-names>F.J.</given-names></name><name><surname>Remacha</surname><given-names>A.R.</given-names></name><name><surname>Bernal</surname><given-names>M.L.</given-names></name><name><surname>Zaragoza</surname><given-names>P.</given-names></name><name><surname>Rodellar</surname><given-names>C.</given-names></name><name><surname>Mart&#x000ed;n-Burriel</surname><given-names>I.</given-names></name></person-group><year>2011</year>
<article-title>Immunophenotype and gene expression profiles of cell surface markers of mesenchymal stem cells
derived from equine bone marrow and adipose tissue</article-title>. <source><italic>Vet. Immunol.
Immunopathol.</italic></source><volume>144</volume>: <fpage>147</fpage>&#x02013;<lpage>154</lpage>
<pub-id pub-id-type="pmid">21782255</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Roulet</surname><given-names>M.</given-names></name><name><surname>Ruggiero</surname><given-names>F.</given-names></name><name><surname>Karsenty</surname><given-names>G.</given-names></name><name><surname>LeGuellec</surname><given-names>D.</given-names></name></person-group><year>2007</year>
<article-title>A comprehensive study of the spatial and temporal expression of the col5a1 gene in mouse
embryos: a clue for understanding collagen V function in developing connective tissues</article-title>. <source><italic>Cell
Tissue Res.</italic></source><volume>327</volume>: <fpage>323</fpage>&#x02013;<lpage>332</lpage>
<pub-id pub-id-type="pmid">17024418</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Shukunami</surname><given-names>C.</given-names></name><name><surname>Oshima</surname><given-names>Y.</given-names></name><name><surname>Hiraki</surname><given-names>Y.</given-names></name></person-group><year>2001</year>
<article-title>Molecular cloning of tenomodulin, a novel chondromodulin-I related gene</article-title>.
<source><italic>Biochem. Biophys. Res. Commun.</italic></source><volume>280</volume>: <fpage>1323</fpage>&#x02013;<lpage>1327</lpage>
<pub-id pub-id-type="pmid">11162673</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Smith</surname><given-names>R.K.</given-names></name><name><surname>Korda</surname><given-names>M.</given-names></name><name><surname>Blunn</surname><given-names>G.W.</given-names></name><name><surname>Goodship</surname><given-names>A.E.</given-names></name></person-group><year>2003</year>
<article-title>Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the
superficial digital flexor tendon as a potential novel treatment</article-title>. <source><italic>Equine Vet.
J.</italic></source><volume>35</volume>: <fpage>99</fpage>&#x02013;<lpage>102</lpage>
<pub-id pub-id-type="pmid">12553472</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Young</surname><given-names>B.B.</given-names></name><name><surname>Gordon</surname><given-names>M.K.</given-names></name><name><surname>Birk</surname><given-names>D.E.</given-names></name></person-group><year>2000</year>
<article-title>Expression of type XIV collagen in developing chicken tendons: association with assembly and
growth of collagen fibrils</article-title>. <source><italic>Dev. Dyn.</italic></source><volume>217</volume>:
<fpage>430</fpage>&#x02013;<lpage>439</lpage>
<pub-id pub-id-type="pmid">10767087</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Ezura</surname><given-names>Y.</given-names></name><name><surname>Chervoneva</surname><given-names>I.</given-names></name><name><surname>Robinson</surname><given-names>P.S.</given-names></name><name><surname>Beason</surname><given-names>D.P.</given-names></name><name><surname>Carine</surname><given-names>E.T.</given-names></name><name><surname>Soslowsky</surname><given-names>L.J.</given-names></name><name><surname>Iozzo</surname><given-names>R.V.</given-names></name><name><surname>Birk</surname><given-names>D.E.</given-names></name></person-group><year>2006</year>
<article-title>Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties
during tendon development</article-title>. <source><italic>J. Cell Biochem.</italic></source><volume>98</volume>:
<fpage>1436</fpage>&#x02013;<lpage>1449</lpage>
<pub-id pub-id-type="pmid">16518859</pub-id></mixed-citation></ref></ref-list></back></article>